NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jan 10, 2020 $111.22 $111.22 $108.77 $109.48 1 080 957
Jan 09, 2020 $109.21 $111.20 $108.83 $110.74 1 788 238
Jan 08, 2020 $106.94 $109.19 $105.73 $108.58 1 737 034
Jan 07, 2020 $104.95 $108.59 $104.58 $106.85 2 992 200
Jan 06, 2020 $105.65 $107.77 $104.56 $106.58 1 640 415
Jan 03, 2020 $106.36 $107.38 $105.18 $106.41 1 268 567
Jan 02, 2020 $109.36 $109.80 $107.16 $107.84 1 391 983
Dec 31, 2019 $106.80 $108.40 $106.70 $108.15 1 135 178
Dec 30, 2019 $108.95 $108.95 $107.10 $107.34 1 002 739
Dec 27, 2019 $108.85 $109.30 $107.81 $108.55 1 153 523
Dec 26, 2019 $110.12 $110.95 $108.52 $108.93 899 294
Dec 24, 2019 $111.10 $111.23 $109.82 $110.28 403 899
Dec 23, 2019 $110.68 $110.98 $109.42 $110.46 1 446 478
Dec 20, 2019 $111.59 $111.94 $107.73 $109.75 3 981 261
Dec 19, 2019 $110.05 $112.36 $109.32 $111.24 2 317 940
Dec 18, 2019 $109.43 $109.74 $107.32 $109.20 1 578 782
Dec 17, 2019 $109.51 $110.12 $106.76 $109.82 1 742 342
Dec 16, 2019 $111.22 $111.80 $110.25 $111.37 1 610 324
Dec 13, 2019 $112.82 $113.79 $109.72 $110.42 1 504 012
Dec 12, 2019 $109.60 $112.84 $109.15 $112.47 1 745 037
Dec 11, 2019 $111.51 $112.87 $108.91 $109.50 1 467 308
Dec 10, 2019 $113.03 $113.54 $110.59 $111.20 1 617 264
Dec 09, 2019 $114.08 $116.20 $111.40 $112.48 1 822 899
Dec 06, 2019 $113.80 $114.79 $109.59 $113.89 4 244 491
Dec 05, 2019 $115.59 $116.00 $106.13 $107.42 3 552 634
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT